Phase I Study of BCD-145 (Anti-CTLA-4) in Patients With Unresectable/Metastatic Melanoma
Clinical trial NCT03472027 · COMPLETED
Trial details
- NCT number
- NCT03472027
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-02
- Primary completion
- 2018-09-11
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.